Literature DB >> 1206577

Lipid A fever in cats.

P K Dey, W Feldberg, K P Gupta, S Wendlandt.   

Abstract

In unanaesthetized cats the effect of lipid A on rectal temperature and on prostaglandin E2 (PGE2) activity in cisternal cerebrospinal fluid (c.s.f.) was examined. Lipid A was injected either intravenously or into the cerebral ventricles. 2. Lipid A injected intravenously in a dose of 1--4 mug/kg produced longlasting fever which was more often biphasic than monophasic. With a second injection a much shorter but usually hither monophasic response was produced. The cat was then for a time insensitive to I.V. lipid A but when the injections were repeated at 24 hr intervals brisk monophasic fevers were again produced. The threshold dose of I.V. lipid A lay between 0-1 and 0-3 mug/kg. 3. Lipid A injected into the cerebral ventricles in a dose of 100 ng or 1 mug produced long-lasting monophasic fever. No tolerance developed; the same or only slightly diminished responses occurred on repeated injections. The threshold dose was between 5 and 20 ng. 4. A cat rendered insensitive to I.V. lipid A gave its normal fever response to injection of lipid A into the cerebral ventricles. 5. The fever produced by lipid A injected I.V. or into the cerebral ventricles was associated with the appearance of, or a rise in PGE2 activity in c.s.f. 6. Both the fever and the PGE2 activity in c.s.f. produced by lipid A injected intravenously or into the cerebral ventricles were brought down and prevented by I.P. injections of aspirin, paracetamol, or indomethacin.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1206577      PMCID: PMC1348535          DOI: 10.1113/jphysiol.1975.sp011182

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  18 in total

1.  [ON FLUORESCENCE OF PERIVASCULAR CELLS IN THE CAT BRAIN].

Authors:  K FLEISCHHAUER
Journal:  Z Zellforsch Mikrosk Anat       Date:  1964-09-17

2.  Pathogenesis of fever.

Authors:  E ATKINS
Journal:  Physiol Rev       Date:  1960-07       Impact factor: 37.312

3.  Prostaglandins of the E and F series in rabbit cerebrospinal fluid during fever induced by Newcastle disease virus, E. coli-endotoxin, or endogenous pyrogen.

Authors:  W K Philipp-Dormston; R Siegert
Journal:  Med Microbiol Immunol       Date:  1974-06-19       Impact factor: 3.402

4.  Mechanisms of endotoxin tolerance. VII. The role of the liver.

Authors:  S E Greisman; C L Woodward
Journal:  J Immunol       Date:  1970-12       Impact factor: 5.422

5.  The hypependymal microglia cell.

Authors:  J Cammermeyer
Journal:  Z Anat Entwicklungsgesch       Date:  1965

6.  The hyperglycaemic effect of morphine.

Authors:  W Feldberg; S V Shaligram
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

7.  ACTIONS OF PROSTAGLANDINS E1, E2 AND E3 ON THE CENTRAL NERVOUS SYSTEM.

Authors:  E W HORTON
Journal:  Br J Pharmacol Chemother       Date:  1964-02

8.  Further studies on the role of prostaglandin in fever.

Authors:  P K Dey; W Feldberg; K P Gupta; A S Milton; S Wendlandt
Journal:  J Physiol       Date:  1974-09       Impact factor: 5.182

9.  Release of an endogenous pyrogen in vitro from rabbit mononuclear cells.

Authors:  E Atkins; P Bodel; L Francis
Journal:  J Exp Med       Date:  1967-08-01       Impact factor: 14.307

10.  Studies on the pathogenesis of fever. II. Characterization of fever-producing substances from polymorphonuclear leukocytes and from the fluid of sterile exudates.

Authors:  I L BENNETT; P B BEESON
Journal:  J Exp Med       Date:  1953-11       Impact factor: 14.307

View more
  2 in total

1.  On the pyrogenic action of intravenous lipid A in rabbits.

Authors:  E Kenedi; H Laburn; D Mitchell; F P Ross
Journal:  J Physiol       Date:  1982-07       Impact factor: 5.182

2.  Mechanisms of fever induced by recombinant human interferon.

Authors:  C A Dinarello; H A Bernheim; G W Duff; H V Le; T L Nagabhushan; N C Hamilton; F Coceani
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.